Speakers and Moderators
These speakers have already confirmed:
 | Richard Bonner UK, Formerly Senior Quality Advisor for Eli Lilly and Company, Chairman ECA and EQPA |
 | Dr Christopher Burgess Chairman of ECA‘s Working Group on Quality Control |
 | Dr Klaus Eichmüller District Government of Upper Bavaria Munich, GMP Inspectorate, Germany |
 | Dr Matthias Heuermann European GMP Inspector, Germany |
 | Dr Afshin Hosseiny Chairman of ECA‘s GDP Interest Group |
 | Dr Jean-Denis Mallet SNC Lavalin, France, ECA Advisory Board Member |
 | Gert Moelgaard NNE Pharmaplan and co-Chair of ECA‘s Working Group on Validation |
 | Dr Bernd Renger Qualified Person, Immediate Past Chairman European QP Association |
 | Dr Renate Schenk-Gröninger Boehringer Ingelheim Pharma, Germany and co-Chair of ECA‘s Working Group on Validation |
 | Dr Thomas Schneppe Bayer Pharma, Germany and co-chair of ECA‘s Working Group on Validation |
Speakers and Moderators of the 4th European GMP Conference
 | Bernd Bödecker Trade & Industry Inspection Agency of Lower Saxony, Hannover office, GMP Inspector. Member of national and international official expert circles dealing with QRM. |
| Matt Moran Pharma Chemical, Ireland Vice President APIC/CEFIC and ECA Advisory Board Member |
| Richard Bonner UK, Formerly Senior Quality Advisor for Eli Lilly and Company, ECA Advisory Board Membe |
| Dr Gabriele Reich University of Heidelberg Senior Lecturer at the Institute of Pharmacy and Molecular Biotechnology (IPMB). |
 | Dr Antony Fake WHO, Switzerland, Technical Officer, Active Pharmaceutical Ingredient Focal Point |  | Dr Wolfgang Schumacher F. Hoffmann-La Roche, Switzerland Member of the IT Quality Unit, ECA Advisory Board Member |
 | Philippe Legoff Managing Director H&LG Consultants, Switzerland |  | Dr Janeth Soreth Deputy Director Europe/US FDA |
 | Silke Mainka Lawyer, Germany. Attorney in the field of international contracting. |
| Ian Thrussel MHRA, UK Expert GMP Inspector of MHRA, Member of ICH Q10 Expert Working Group |
 | Dr Jean-Denis Mallet SNC Lavalin, France, ECA Advisory Board Member |
| Lionel Viornéry AFSSAPS, France Head of the Starting Material Inspection Unit of AFSSAPS |
 | Julie Maréchal-Jamil Senior Manager Regulatory Affairs at the European Generic Medicines Association (EGA) |
| Rudolf Völler Regional Council Darmstadt, Germany Senior GMP Inspector and ECA Advisory Board Member |
 | Grace McNally Senior Senior Policy Advisor, US FDA |  | Dr Grace Yi-Ni Ye SFDA, China |
| Gert Moelgaard Vice President NNE Pharmaplan, Denmark |
Speakers and Moderators of the 3rd European GMP Conference
| (picture not available) | Mr Thomas J. Arista Mr. Arista is a member of the Office of Regulatory Affairs (ORA) Field Investigator National Expert Cadre at FDA |  | Dr Gabriele Reich University of Heidelberg Senior Lecturer at the Institute of Pharmacy and Molecular Biotechnology (IPMB). |
 | Hélène Bruguera European Directorate for the Quality of Medicines (EDQM & Health Care), France Deputy Head of Division and in charge of the management of revisions of CEPs. | | Dr Bernd Renger Vetter Pharma-Fertigung GmbH & Co. KG, Germany Director of Quality Control, Chairman European QP Association |
| Dr Christopher Burgess Burgess Consultancy, Barnard Castle, UK Qualified Person and a member of the European QP Association Advisory Board |  | Benoît Rime United States Pharmacopeia (USP), USA Senior International account manager, Mainland Western Europe |
 | Eileen Counihan Merck Sharp & Dohme Ltd, Ireland. Director Commercialization and EMEA Compliance |  | Daniel Scheidegger Genzyme, Switzerland Managing Director Genzyme Switzerland, Chairman ECA |
 | Dr Josef Hofer Director of exdra GmbH (excellence in drug regulatory affairs.) and assistant lecturer at the University in Bonn for Regulatory Affairs. | | Dr Thomas Schneppe Since 2006 Bayer Schering Pharma; Head of Mgmt. Training at Bayer Health Care - Product Supply - Compliance - Integrated Quality Mgmt. |
| Dr Jean-Denis Mallet International Committee Red Cross Pharmaceutics, Switzerland |  | Dr Stephan Schwarze Head of Counterfeit Protection Management since 2005 within Bayer Schering Pharma AG. He is a member of WHO IMPACT's Technology Subgroup as well as of EFPIA's Anti-Counterfeiting ad hoc working group. |
 | Dr Heinrich Prinz Dr Prinz is senior supervisor of Quality Control and Quality Assurance at CellMed AG and works also as a freelance Consultant. | | Dr Wolfgang Schumacher F. Hoffmann-La Roche, Switzerland Member of the IT Quality Unit, ECA Advisory Board Member |
 | Dr Boris Pimentel DNP (DSM-Nutritional Products), Switzerland Vice President APIC/CEFIC and ECA Advisory Board Member |  | Dr Michael Ulmschneider Member of the PAT and analytical business process group at Hoffmann-La Roche in Basel |
 | Frederick W. Blumenschein FDA, USA Chief, Case Management and Guidance Branch Division of Manufacturing and Product Quality Office of Compliance |  | Dr Johanna Eisele Degussa Pharma Polymers, Germany Member of IPEC Europe RA & GMP Committee |
 | David Cockburn EMEA, UK Principal Scientific Administrator, Inspections Sector |  | Dr Ludwig Huber Agilent Technologies, Germany ECA Advisory Board Member |
 | Dr Jacques Morénas AFSSAPS, France Member of ICH Expert Working Group (Q9 and Q10), Chairman PIC/S |  | Dr Michael Jahnke Wülfing Pharma GmbH, Germany Head of Quality Assurance Wülfing Pharma |
 | Dr Susanne Keitel BfArM, Germany Head of EU and International Affairs at BfArM and Member of the ICH Q8 Working Group |  | Kenneth J. Leiper Benson Associates Chair of ASTM Pharmaceutical Application of Process Analytical Technology Committee E55.01 |
 | John Taylor MHRA, UK Quality and Standards Manager Acting and Group Manager, Enforcement and Intelligence |  | Matt Moran PharmaChemical, Ireland President APIC/CEFIC and ECA Advisory Board Member |
 | Dr Sabine Paris ZLG, Germany Head of Department Medicinal Products / Central Coordination Unit | | Dr Boris Pimentel DNP (DSM-Nutritional Products), Switzerland Vice President APIC/CEFIC and ECA Advisory Board Member |
 | Dr Dirk Barends RIVM Senior Scientist Working on NIRS/PAT within RIVM | | Dr Gabriele Reich University of Heidelberg Senior Lecturer at the Institute of Pharmacy and Molecular Biotechnology (IPMB) |
 | Rudolf Völler Regional Council Darmstadt, Germany Senior GMP Inspector and ECA Advisory Board Member | | Dr Bernd Renger Vetter Pharma-Fertigung GmbH & Co. KG, Germany Director of Quality Control, Chairman European QP Association |
 | Dr Jürgen Mählitz District Government of Upper Bavaria, Germany GMP Inspector | | Daniel Scheidegger Genzyme, Switzerland Managing Director Genzyme Switzerland, Chairman ECA |
 | Dr John Berridge Member of the ICH Q8 Working Group |  | Jef Van Schuerbeek Consultant, Belgium Formerly in pharmaceutical R&D at Lilly Clinical Operations |
| Richard Bonner UK, Formerly Senior Quality Advisor for Eli Lilly and Company, ECA Advisory Board Member | | Dr Wolfgang Schumacher F. Hoffmann-La Roche, Switzerland Member of the IT Quality Unit, ECA Advisory Board Member |
 | Colin Booth Oxoid Limited, UK Vice President Science and Technology at Oxoid, ECA Advisory Board Member |